The compounding loophole for GLP-1 drugs.

Scott Alexander once wondered how the economy would handle a $12,000/yr drug that everybody wants (i.e. Ozempic). We haven’t seen the official price become the market price, though, because patent protections for the drug are currently suspended. That’s the compounding loophole. ~ learn more